Glaukos (GKOS) Financials

$97.05 +1.03 (+1.08%)

Closing price 05/27/2025 03:59 PM Eastern

Extended Trading

$96.97 -0.08 (-0.09%)

As of 05/27/2025 04:20 PM Eastern

Annual Income Statements for Glaukos

This table shows Glaukos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-37
Consolidated Net Income / (Loss)	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-38
Net Income / (Loss) Continuing Operations	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-38
Total Pre-Tax Income	-146	-134	-98	-49	-132	-50	-12	0.00	4.57	-38
Total Operating Income	-122	-129	-82	-33	-124	-50	-13	-2.28	4.24	-10
Total Gross Profit	289	239	214	227	133	198	156	138	98	59
Total Revenue	383	315	283	294	225	237	181	159	114	72
Operating Revenue	383	315	283	294	225	237	181	159	114	72
Total Cost of Revenue	94	76	69	67	92	39	25	21	16	13
Operating Cost of Revenue	94	76	69	67	92	39	25	21	16	13
Total Operating Expenses	412	368	296	260	257	249	169	140	94	69
Selling, General & Admin Expense	261	224	193	179	171	177	-	96	65	44
Research & Development Expense	151	144	133	111	85	72	50	44	29	25
Other Special Charges / (Income)	0.00	0.00	-30	-30	-	0.00	-	-	-	-
Total Other Income / (Expense), net	-23	-5.03	-16	-16	-8.76	0.51	0.63	2.28	0.32	-28
Interest Expense	34	14	18	18	11	2.91	1.62	-0.91	-	1.26
Interest & Investment Income	11	9.16	2.38	1.29	2.38	3.17	2.25	1.38	0.89	-26
Income Tax Expense	0.77	0.93	0.77	0.33	-12	-65	0.58	0.09	0.04	0.03
Basic Earnings per Share	($2.77)	($2.78)	($2.09)	($1.07)	($2.70)	$0.41	($0.37)	$0.00	$0.14	($2.13)
Weighted Average Basic Shares Outstanding	52.76M	48.43M	47.44M	46.42M	44.50M	37.36M	35.32M	34.38M	32.93M	17.47M
Diluted Earnings per Share	($2.77)	($2.78)	($2.09)	($1.07)	($2.70)	$0.37	($0.37)	$0.00	$0.12	($2.13)
Weighted Average Diluted Shares Outstanding	52.76M	48.43M	47.44M	46.42M	44.50M	41.15M	35.32M	34.38M	36.46M	17.47M
Weighted Average Basic & Diluted Shares Outstanding	56.57M	49.47M	47.88M	47.05M	45.79M	43.74M	35M	34.74M	32.30M	17.50M

This table shows Glaukos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-18	-34	-21	-51	-41	-37	-30	-33	-35	-31	-28
Consolidated Net Income / (Loss)	-18	-34	-21	-51	-41	-37	-30	-33	-35	-31	-28
Net Income / (Loss) Continuing Operations	-18	-34	-21	-51	-41	-37	-30	-33	-35	-31	-28
Total Pre-Tax Income	-18	-34	-21	-50	-40	-37	-30	-32	-34	-31	-27
Total Operating Income	-21	-29	-25	-30	-39	-39	-28	-29	-33	-34	-22
Total Gross Profit	82	77	74	73	65	63	60	60	56	54	54
Total Revenue	107	105	97	96	86	82	78	80	74	71	71
Operating Revenue	107	105	97	96	86	82	78	80	74	71	71
Total Cost of Revenue	24	29	23	23	20	19	19	20	18	17	17
Operating Cost of Revenue	24	29	23	23	20	19	19	20	18	17	17
Total Operating Expenses	103	106	99	103	104	102	88	89	89	88	76
Selling, General & Admin Expense	71	69	64	66	62	63	54	53	54	52	47
Research & Development Expense	32	37	35	37	42	39	33	36	35	36	29
Total Other Income / (Expense), net	2.86	-5.03	3.43	-20	-1.40	1.90	-2.40	-3.30	-1.23	2.57	-5.72
Interest Expense	1.16	7.86	1.66	21	3.45	3.99	3.40	3.40	3.41	8.18	3.48
Interest & Investment Income	3.08	2.49	2.70	2.83	3.08	2.38	2.71	1.89	2.18	3.94	-2.24
Other Income / (Expense), net	0.95	-	2.39	-1.70	-1.03	-	-1.71	-1.80	-	-	-
Income Tax Expense	0.33	-0.11	0.18	0.33	0.38	0.06	0.04	0.44	0.40	0.30	0.25
Basic Earnings per Share	($0.32)	($0.56)	($0.39)	($1.00)	($0.82)	($0.75)	($0.63)	($0.68)	($0.72)	($0.66)	($0.58)
Weighted Average Basic Shares Outstanding	56.64M	52.76M	55.04M	50.72M	49.58M	48.43M	48.68M	48.28M	47.88M	47.44M	47.61M
Diluted Earnings per Share	($0.32)	($0.56)	($0.39)	($1.00)	($0.82)	($0.75)	($0.63)	($0.68)	($0.72)	($0.66)	($0.58)
Weighted Average Diluted Shares Outstanding	56.64M	52.76M	55.04M	50.72M	49.58M	48.43M	48.68M	48.28M	47.88M	47.44M	47.61M
Weighted Average Basic & Diluted Shares Outstanding	57.14M	56.57M	55.14M	54.95M	50.37M	49.47M	48.80M	48.65M	48.21M	47.88M	47.70M

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	75	-27	16	3.96	34	33	14	18	-15	19
Net Cash From Operating Activities	-61	-58	-33	25	-23	-0.37	19	26	12	-2.19
Net Cash From Continuing Operating Activities	-61	-58	-33	25	-23	-0.37	19	26	12	-2.19
Net Income / (Loss) Continuing Operations	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-38
Consolidated Net Income / (Loss)	-146	-135	-99	-50	-120	15	-13	-0.09	4.52	-38
Depreciation Expense	11	8.74	6.66	4.75	4.47	6.31	6.26	5.48	4.72	4.27
Amortization Expense	30	25	31	32	61	3.22	-0.30	0.02	0.21	0.07
Non-Cash Adjustments To Reconcile Net Income	84	54	42	35	47	49	28	17	9.15	35
Changes in Operating Assets and Liabilities, net	-40	-10	-14	2.55	-15	-75	-1.66	4.03	-6.30	-3.38
Net Cash From Investing Activities	48	14	45	-58	-205	43	-26	-12	-26	-86
Net Cash From Continuing Investing Activities	48	14	45	-58	-205	43	-26	-12	-26	-86
Purchase of Property, Plant & Equipment	-6.30	-20	-30	-48	-6.94	-4.72	-10	-6.31	-6.28	-0.88
Purchase of Investments	-190	-266	-59	-215	-301	-80	-94	-94	-75	-70
Sale of Property, Plant & Equipment	0.04	0.00	0.15	0.00	0.00	0.00	-	-	-	-
Sale and/or Maturity of Investments	247	303	135	207	105	80	79	89	55	-
Other Investing Activities, net	-3.15	-3.17	-1.01	-2.08	-1.82	-1.61	-1.24	-0.66	-	-15
Net Cash From Financing Activities	92	15	6.25	39	263	-9.65	22	4.67	-1.64	107
Net Cash From Continuing Financing Activities	92	15	6.25	39	263	-9.65	22	4.67	-1.64	107
Repayment of Debt	-0.71	0.00	0.00	0.00	-9.61	-22	0.00	-	-9.70	-18
Issuance of Debt	53	0.00	0.00	-	288	0.00	0.00	-	-	8.60
Issuance of Common Equity	7.42	6.28	5.63	4.82	4.03	3.39	3.51	0.97	1.95	115
Other Financing Activities, net	32	8.76	0.62	34	-19	9.46	18	3.70	6.11	2.16
Effect of Exchange Rate Changes	-3.02	1.34	-1.47	-1.77	-0.09	-0.25	0.05	-0.43	0.37	-0.03
Cash Interest Paid	9.21	12	12	12	5.38	0.00	0.00	-	0.29	0.83
Cash Income Taxes Paid	1.36	1.56	0.52	0.27	0.48	0.17	0.40	0.01	0.51	0.03

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-55	69	32	24	-51	-15	14	17	-43	14	1.42
Net Cash From Operating Activities	-19	0.51	-9.59	-18	-34	-11	-8.17	-8.16	-31	-4.14	-27
Net Cash From Continuing Operating Activities	-19	0.51	-9.59	-18	-34	-11	-8.17	-8.16	-31	-4.14	-27
Net Income / (Loss) Continuing Operations	-18	-34	-21	-51	-41	-37	-30	-33	-35	-31	-28
Consolidated Net Income / (Loss)	-18	-34	-21	-51	-41	-37	-30	-33	-35	-31	-28
Depreciation Expense	2.65	2.77	2.74	2.75	2.69	2.29	2.23	2.15	2.08	1.95	1.67
Amortization Expense	5.51	13	5.36	5.38	5.46	5.93	5.87	6.29	6.52	10	6.73
Non-Cash Adjustments To Reconcile Net Income	15	16	14	32	21	13	13	16	12	7.80	13
Changes in Operating Assets and Liabilities, net	-23	1.68	-11	-8.23	-22	4.95	1.00	0.25	-16	7.23	-20
Net Cash From Investing Activities	-37	12	31	35	-29	-13	15	26	-14	17	24
Net Cash From Continuing Investing Activities	-37	12	31	35	-29	-13	15	26	-14	17	24
Purchase of Property, Plant & Equipment	-1.94	-1.73	-1.45	-2.15	-0.97	-4.21	-3.36	-5.77	-6.91	-8.22	-6.04
Purchase of Investments	-75	-67	-32	-42	-49	-72	-23	-74	-96	-12	-10
Sale and/or Maturity of Investments	41	80	65	80	22	64	42	107	90	38	41
Other Investing Activities, net	-1.15	0.08	-1.15	-1.04	-1.05	-1.02	-0.10	-1.52	-0.53	-0.84	0.00
Net Cash From Financing Activities	1.95	60	9.67	8.59	13	7.30	7.47	-0.88	1.15	0.53	4.21
Net Cash From Continuing Financing Activities	1.95	60	9.67	8.59	13	7.30	7.47	-0.88	1.15	0.53	4.21
Issuance of Common Equity	2.96	-	4.73	-	2.69	-	4.12	-	2.16	-	3.85
Other Financing Activities, net	-1.01	7.60	4.94	8.59	10	7.30	3.35	-0.88	-1.01	0.53	0.36
Other Net Changes in Cash	-1.86	-	-	-	-	-	-	-	-	-	-
Cash Interest Paid	1.06	1.86	1.08	5.20	1.07	5.06	1.08	5.03	1.09	5.04	1.16
Cash Income Taxes Paid	0.28	0.20	0.36	0.45	0.35	0.34	0.44	0.53	0.26	0.15	0.13

This table presents Glaukos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	975	940	1,002	1,050	1,006	818	207	166	134	117
Total Current Assets	450	395	444	486	469	263	177	149	120	104
Cash & Equivalents	170	93	120	101	97	62	30	25	6.49	22
Short-Term Investments	149	202	233	313	308	112	111	95	89	70
Accounts Receivable	61	40	36	33	36	38	19	17	14	7.55
Inventories, net	58	42	38	23	16	43	13	11	6.84	4.10
Prepaid Expenses	12	18	17	16	13	7.90	4.12	2.57	3.03	1.29
Plant, Property, & Equipment, net	98	103	94	69	24	22	19	12	7.59	2.15
Total Noncurrent Assets	427	442	464	495	512	533	11	4.58	6.76	10
Noncurrent Note & Lease Receivables	42	44	47	49	51	54	-	-	-	-
Goodwill	66	66	66	66	66	66	-	-	-	-
Intangible Assets	263	283	308	333	358	383	-	3.15	6.57	10
Other Noncurrent Operating Assets	51	43	36	37	27	21	2.26	1.20	0.19	0.15
Other Noncurrent Nonoperating Assets	4.73	5.86	7.08	9.42	9.57	9.33	8.78	-	-	-
Total Liabilities & Shareholders' Equity	975	940	1,002	1,050	1,006	818	207	166	134	117
Total Liabilities	208	479	472	463	338	145	33	28	17	21
Total Current Liabilities	75	74	72	63	50	58	30	27	17	20
Accounts Payable	13	13	14	7.33	4.37	5.78	6.29	6.24	2.97	3.63
Accrued Expenses	62	61	58	56	45	52	24	20	14	7.79
Total Noncurrent Liabilities	133	405	400	399	288	87	2.75	0.85	0.16	1.11
Long-Term Debt	0.00	283	281	280	189	0.00	-	-	-	0.77
Noncurrent Deferred & Payable Income Tax Liabilities	6.93	7.14	7.26	7.32	11	9.63	-	-	-	-
Other Noncurrent Operating Liabilities	126	115	111	112	88	78	2.75	0.85	0.16	0.34
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	767	462	530	587	667	673	174	138	117	95
Total Preferred & Common Equity	767	462	530	587	667	673	174	138	117	95
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	767	462	530	587	667	673	174	138	117	95
Common Stock	1,510	1,060	998	952	977	862	378	331	309	292
Retained Earnings	-745	-599	-464	-365	-310	-190	-205	-192	-192	-197
Treasury Stock	-0.13	-0.13	-0.13	-	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13
Accumulated Other Comprehensive Income / (Loss)	2.62	1.17	-2.98	0.02	1.00	1.33	0.74	-0.59	0.65	0.05

This table presents Glaukos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	966	927	920	933	949	957	973	1,008
Total Current Assets	445	397	384	389	400	401	416	449
Cash & Equivalents	114	100	68	42	109	95	76	104
Short-Term Investments	184	162	194	230	192	209	241	258
Accounts Receivable	72	56	51	47	39	39	38	35
Inventories, net	59	60	56	50	40	39	40	34
Prepaid Expenses	15	19	14	19	20	19	20	18
Plant, Property, & Equipment, net	97	99	100	102	103	103	98	87
Total Noncurrent Assets	425	431	436	443	446	453	458	463
Noncurrent Note & Lease Receivables	41	42	43	44	45	45	46	47
Goodwill	66	66	66	66	66	66	66	66
Intangible Assets	258	269	276	282	289	295	302	314
Other Noncurrent Operating Assets	55	48	46	45	40	40	38	26
Other Noncurrent Nonoperating Assets	4.73	4.73	4.73	5.86	5.86	5.86	7.08	9.08
Total Liabilities & Shareholders' Equity	966	927	920	933	949	957	973	1,008
Total Liabilities	202	258	255	483	471	468	464	460
Total Current Liabilities	69	72	70	72	67	64	62	61
Accounts Payable	16	11	12	13	10	8.56	12	11
Accrued Expenses	53	61	59	59	57	55	50	49
Total Noncurrent Liabilities	134	186	184	410	404	404	402	399
Noncurrent Deferred & Payable Income Tax Liabilities	6.92	7.14	7.14	7.14	7.25	7.26	7.26	7.30
Other Noncurrent Operating Liabilities	127	122	121	120	114	115	113	111
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	764	669	665	451	478	489	509	549
Total Preferred & Common Equity	764	669	665	451	478	489	509	549
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	764	669	665	451	478	489	509	549
Common Stock	1,525	1,378	1,354	1,089	1,039	1,021	1,009	985
Retained Earnings	-764	-712	-690	-640	-562	-532	-499	-433
Treasury Stock	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13
Accumulated Other Comprehensive Income / (Loss)	2.61	2.62	2.19	1.44	0.76	-0.39	-1.33	-3.82

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	21.85%	11.26%	-3.79%	30.70%	-5.07%	30.73%	13.83%	39.21%	59.55%	57.28%
EBITDA Growth	14.30%	-111.93%	-1,239.09%	106.83%	-42.68%	-476.01%	-318.35%	-62.58%	221.32%	20.59%
EBIT Growth	4.92%	-56.35%	-150.40%	73.39%	-146.93%	-284.83%	-470.01%	-162.05%	132.17%	13.20%
NOPAT Growth	4.92%	-56.35%	-150.40%	73.39%	-145.67%	-286.80%	-104.34%	4,895.23%	158.29%	21.83%
Net Income Growth	-8.70%	-35.75%	-100.02%	58.79%	-880.26%	219.10%	-13,977.17%	-102.03%	111.80%	-172.61%
EPS Growth	0.36%	-33.01%	-95.33%	60.37%	-829.73%	200.00%	0.00%	-100.00%	105.63%	59.74%
Operating Cash Flow Growth	-6.16%	-74.59%	-233.90%	207.48%	-6,129.81%	-101.96%	-27.70%	111.97%	662.57%	69.21%
Free Cash Flow Firm Growth	-4.87%	-24.67%	-175.51%	39.71%	92.12%	-3,349.74%	-106.84%	6,077.99%	52.24%	67.24%
Invested Capital Growth	0.01%	-1.86%	1.79%	0.18%	-9.60%	1,891.96%	28.19%	-10.47%	56.63%	1.65%
Revenue Q/Q Growth	6.42%	3.67%	-0.71%	0.00%	3.39%	5.23%	7.36%	5.62%	12.71%	0.00%
EBITDA Q/Q Growth	14.33%	-11.32%	-40.25%	-89.48%	46.40%	-216.34%	12.12%	8.56%	32.37%	0.00%
EBIT Q/Q Growth	7.52%	-3.95%	-23.88%	-24.54%	12.90%	-167.60%	9.50%	2.73%	107.92%	0.00%
NOPAT Q/Q Growth	7.52%	-3.95%	-23.88%	-24.54%	12.90%	-168.97%	9.50%	12,884.16%	137.62%	0.00%
Net Income Q/Q Growth	2.14%	-4.11%	-10.70%	-29.25%	-64.59%	179.60%	5.63%	90.46%	115.54%	0.00%
EPS Q/Q Growth	6.42%	-3.35%	-10.58%	-30.49%	-75.32%	169.81%	2.63%	100.00%	-98.73%	0.00%
Operating Cash Flow Q/Q Growth	15.41%	-12.74%	1.53%	-38.17%	39.16%	-101.76%	32.86%	54.32%	76.73%	-43.57%
Free Cash Flow Firm Q/Q Growth	11.95%	10.10%	-22.92%	-129.86%	92.43%	-3,062.04%	-17.57%	4,048.54%	0.00%	0.00%
Invested Capital Q/Q Growth	-3.23%	-2.23%	0.55%	0.31%	-1.68%	1,630.34%	-3.82%	-17.61%	9.58%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	75.48%	75.99%	75.61%	77.34%	59.23%	83.72%	86.17%	86.78%	85.86%	81.89%
EBITDA Margin	-21.31%	-30.30%	-15.91%	1.34%	-25.69%	-17.09%	-3.88%	2.02%	7.52%	-9.90%
Operating Margin	-31.91%	-40.89%	-29.10%	-11.18%	-54.92%	-21.22%	-7.17%	-1.43%	3.71%	-14.36%
EBIT Margin	-31.91%	-40.89%	-29.10%	-11.18%	-54.92%	-21.11%	-7.17%	-1.43%	3.21%	-15.94%
Profit (Net Income) Margin	-38.17%	-42.79%	-35.07%	-16.87%	-53.50%	6.51%	-7.14%	-0.06%	3.95%	-53.45%
Tax Burden Percent	100.53%	100.70%	100.78%	100.66%	90.96%	-30.83%	104.71%	-9,200.00%	99.06%	100.09%
Interest Burden Percent	118.99%	103.91%	119.58%	149.88%	107.09%	100.00%	95.12%	-0.04%	124.18%	335.04%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9,300.00%	0.94%	0.00%
Return on Invested Capital (ROIC)	-19.32%	-20.13%	-12.87%	-5.19%	-18.54%	-13.68%	-41.57%	1,033.24%	23.93%	-53.10%
ROIC Less NNEP Spread (ROIC-NNEP)	16.17%	71.87%	24.62%	9.26%	-1.94%	-44.13%	-38.70%	1,228.67%	23.57%	43.34%
Return on Net Nonoperating Assets (RNNOA)	-4.50%	-7.02%	-4.89%	-2.72%	0.59%	17.32%	33.27%	-1,033.32%	-19.67%	-30.51%
Return on Equity (ROE)	-23.83%	-27.16%	-17.76%	-7.91%	-17.95%	3.64%	-8.30%	-0.07%	4.26%	-83.61%
Cash Return on Invested Capital (CROIC)	-19.33%	-18.26%	-14.64%	-5.37%	-8.46%	-194.56%	-66.28%	1,044.29%	-20.21%	-54.74%
Operating Return on Assets (OROA)	-12.78%	-13.25%	-8.02%	-3.20%	-13.55%	-9.76%	-6.98%	-1.52%	2.93%	-16.02%
Return on Assets (ROA)	-15.29%	-13.86%	-9.67%	-4.83%	-13.20%	3.01%	-6.95%	-0.06%	3.60%	-53.72%
Return on Common Equity (ROCE)	-23.83%	-27.16%	-17.76%	-7.91%	-17.95%	3.64%	-8.30%	-0.07%	4.26%	51.18%
Return on Equity Simple (ROE_SIMPLE)	-19.09%	-29.16%	-18.72%	-8.45%	-18.03%	2.29%	-7.45%	-0.07%	3.86%	-40.26%
Net Operating Profit after Tax (NOPAT)	-86	-90	-58	-23	-86	-35	-9.10	210	4.20	-7.21
NOPAT Margin	-22.34%	-28.63%	-20.37%	-7.83%	-38.45%	-14.86%	-5.02%	131.77%	3.67%	-10.05%
Net Nonoperating Expense Percent (NNEP)	-35.49%	-92.01%	-37.49%	-14.45%	-16.61%	30.45%	-2.87%	-195.43%	0.36%	-96.44%
Return On Investment Capital (ROIC_SIMPLE)	-11.17%	-12.10%	-7.10%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	24.52%	24.01%	24.39%	22.66%	40.77%	16.28%	13.83%	13.22%	14.14%	18.11%
SG&A Expenses to Revenue	68.10%	71.20%	68.20%	60.97%	76.19%	74.53%	0.00%	60.44%	56.61%	61.31%
R&D to Revenue	39.29%	45.68%	47.12%	37.75%	37.96%	30.40%	27.40%	27.77%	25.55%	34.93%
Operating Expenses to Revenue	107.39%	116.88%	104.71%	88.52%	114.15%	104.94%	93.34%	88.21%	82.15%	96.25%
Earnings before Interest and Taxes (EBIT)	-122	-129	-82	-33	-124	-50	-13	-2.28	3.68	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-82	-95	-45	3.95	-58	-41	-7.03	3.22	8.61	-7.10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	10.78	8.40	3.93	3.55	5.07	2.99	11.64	6.42	9.81	8.33
Price to Tangible Book Value (P/TBV)	18.90	34.43	13.36	11.07	13.89	8.96	11.64	6.56	10.39	9.33
Price to Revenue (P/Rev)	21.56	12.33	7.37	7.09	15.04	8.49	11.16	5.57	10.06	11.05
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	130.41	0.00	0.00	254.48	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.77%	0.00%	0.00%	0.39%	0.00%
Enterprise Value to Invested Capital (EV/IC)	17.93	8.72	4.46	4.39	7.15	3.75	76.56	40.00	49.22	51.97
Enterprise Value to Revenue (EV/Rev)	20.73	12.29	7.11	6.63	14.09	7.75	10.39	4.82	9.22	9.92
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	493.61	0.00	0.00	0.00	238.31	122.55	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	286.97	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.66	251.10	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	78.91	0.00	0.00	99.83	29.42	85.70	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.62	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.61	0.53	0.48	0.28	0.00	0.00	0.00	0.00	0.10
Long-Term Debt to Equity	0.00	0.61	0.53	0.48	0.28	0.00	0.00	0.00	0.00	0.01
Financial Leverage	-0.28	-0.10	-0.20	-0.29	-0.30	-0.39	-0.86	-0.84	-0.83	-0.70
Leverage Ratio	1.56	1.96	1.84	1.64	1.36	1.21	1.19	1.18	1.18	1.56
Compound Leverage Factor	1.85	2.04	2.20	2.46	1.46	1.21	1.14	0.00	1.47	5.22
Debt to Total Capital	0.00%	37.98%	34.68%	32.29%	22.11%	0.00%	0.00%	0.00%	0.00%	9.24%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.51%
Long-Term Debt to Total Capital	0.00%	37.98%	34.68%	32.29%	22.11%	0.00%	0.00%	0.00%	0.00%	0.73%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	62.02%	65.32%	67.71%	77.89%	100.00%	100.00%	100.00%	100.00%	90.76%
Debt to EBITDA	0.00	-2.97	-6.25	70.89	-3.28	0.00	0.00	0.00	0.00	-1.37
Net Debt to EBITDA	0.00	0.13	1.58	-33.93	3.72	0.00	0.00	0.00	0.00	11.49
Long-Term Debt to EBITDA	0.00	-2.97	-6.25	70.89	-3.28	0.00	0.00	0.00	0.00	-0.11
Debt to NOPAT	0.00	-3.14	-4.88	-12.17	-2.19	0.00	0.00	0.00	0.00	-1.35
Net Debt to NOPAT	0.00	0.14	1.24	5.82	2.49	0.00	0.00	0.00	0.00	11.31
Long-Term Debt to NOPAT	0.00	-3.14	-4.88	-12.17	-2.19	0.00	0.00	0.00	0.00	-0.11
Altman Z-Score	23.24	4.26	2.45	2.88	5.89	8.38	36.80	19.43	40.24	20.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	161.21%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.99	5.34	6.13	7.67	9.45	4.56	5.81	5.58	7.09	5.11
Quick Ratio	5.05	4.53	5.37	7.06	8.86	3.68	5.24	5.06	6.50	4.85
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-86	-82	-66	-24	-39	-501	-15	212	-3.55	-7.43
Operating Cash Flow to CapEx	-979.21%	-285.25%	-109.86%	51.71%	-331.48%	-7.81%	182.88%	413.42%	196.07%	-249.49%
Free Cash Flow to Firm to Interest Expense	-2.50	-5.76	-3.54	-1.35	-3.54	-171.84	-8.97	0.00	0.00	-5.91
Operating Cash Flow to Interest Expense	-1.79	-4.07	-1.79	1.40	-2.06	-0.13	11.66	0.00	0.00	-1.74
Operating Cash Flow Less CapEx to Interest Expense	-1.97	-5.50	-3.42	-1.30	-2.69	-1.75	5.28	0.00	0.00	-2.44
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.40	0.32	0.28	0.29	0.25	0.46	0.97	1.06	0.91	1.01
Accounts Receivable Turnover	7.62	8.29	8.14	8.46	6.04	8.30	10.26	10.29	10.47	11.08
Inventory Turnover	1.89	1.89	2.27	3.43	3.14	1.38	2.05	2.33	2.96	4.09
Fixed Asset Turnover	3.81	3.19	3.46	6.32	9.77	11.50	11.72	16.43	23.47	34.94
Accounts Payable Turnover	7.11	5.43	6.35	11.39	18.07	6.40	4.00	4.57	4.91	3.75
Days Sales Outstanding (DSO)	47.87	44.03	44.85	43.14	60.42	43.96	35.57	35.48	34.86	32.95
Days Inventory Outstanding (DIO)	193.44	192.77	161.00	106.33	116.18	264.19	178.34	156.63	123.43	89.30
Days Payable Outstanding (DPO)	51.37	67.24	57.51	32.06	20.20	57.07	91.20	79.86	74.38	97.29
Cash Conversion Cycle (CCC)	189.95	169.56	148.34	117.41	156.40	251.08	122.72	112.25	83.92	24.96
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	443	443	452	444	443	490	25	19	21	14
Invested Capital Turnover	0.87	0.70	0.63	0.66	0.48	0.92	8.28	7.84	6.52	5.28
Increase / (Decrease) in Invested Capital	0.03	-8.38	7.92	0.78	-47	465	5.41	-2.24	7.75	0.22
Enterprise Value (EV)	7,948	3,866	2,012	1,950	3,169	1,837	1,883	768	1,055	711
Market Capitalization	8,267	3,879	2,084	2,084	3,384	2,011	2,024	887	1,151	793
Book Value per Share	$13.91	$9.46	$11.11	$12.52	$14.84	$18.23	$4.83	$4.00	$3.50	$2.97
Tangible Book Value per Share	$7.93	$2.31	$3.27	$4.01	$5.42	$6.08	$4.83	$3.91	$3.30	$2.65
Total Capital	767	745	811	867	857	673	174	138	117	105
Total Debt	0.00	283	281	280	189	0.00	0.00	0.00	0.00	9.70
Total Long-Term Debt	0.00	283	281	280	189	0.00	0.00	0.00	0.00	0.77
Net Debt	-319	-13	-71	-134	-215	-174	-140	-119	-96	-82
Capital Expenditures (CapEx)	6.26	20	30	48	6.94	4.72	10	6.31	6.28	0.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)	56	26	19	8.72	15	31	5.71	3.66	7.24	1.51
Debt-free Net Working Capital (DFNWC)	375	321	372	423	420	205	146	123	103	93
Net Working Capital (NWC)	375	321	372	423	420	205	146	123	103	84
Net Nonoperating Expense (NNE)	61	45	42	27	34	-51	3.85	210	-0.32	31
Net Nonoperating Obligations (NNO)	-324	-19	-78	-143	-225	-183	-149	-119	-96	-82
Total Depreciation and Amortization (D&A)	41	33	37	37	66	9.53	5.97	5.50	4.93	4.33
Debt-free, Cash-free Net Working Capital to Revenue	14.54%	8.27%	6.65%	2.96%	6.83%	13.16%	3.15%	2.30%	6.33%	2.10%
Debt-free Net Working Capital to Revenue	97.70%	102.14%	131.34%	143.79%	186.59%	86.58%	80.65%	77.03%	90.11%	129.30%
Net Working Capital to Revenue	97.70%	102.14%	131.34%	143.79%	186.59%	86.58%	80.65%	77.03%	90.11%	116.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.77)	($2.78)	$0.00	$0.00	($2.70)	$0.41	($0.37)	$0.00	$0.14	($2.13)
Adjusted Weighted Average Basic Shares Outstanding	52.76M	48.43M	0.00	0.00	44.50M	37.36M	35.32M	34.38M	32.93M	32.34M
Adjusted Diluted Earnings per Share	($2.77)	($2.78)	$0.00	$0.00	($2.70)	$0.37	($0.37)	$0.00	$0.12	($2.13)
Adjusted Weighted Average Diluted Shares Outstanding	52.76M	48.43M	0.00	0.00	44.50M	41.15M	35.32M	34.38M	36.46M	32.34M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	($2.13)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	56.57M	49.47M	0.00	0.00	45.79M	43.74M	36.16M	34.74M	34.23M	17.47M
Normalized Net Operating Profit after Tax (NOPAT)	-86	-90	-79	-44	-86	-35	-9.10	-1.60	4.20	-7.21
Normalized NOPAT Margin	-22.34%	-28.63%	-27.79%	-14.97%	-38.45%	-14.86%	-5.02%	-1.00%	3.67%	-10.05%
Pre Tax Income Margin	-37.97%	-42.49%	-34.80%	-16.76%	-58.82%	-21.11%	-6.82%	0.00%	3.99%	-53.40%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.56	-9.07	-4.45	-1.86	-11.09	-17.18	-8.04	0.00	0.00	-9.09
NOPAT to Interest Expense	-2.49	-6.35	-3.12	-1.30	-7.76	-12.09	-5.63	0.00	0.00	-5.73
EBIT Less CapEx to Interest Expense	-3.75	-10.50	-6.08	-4.56	-11.71	-18.80	-14.41	0.00	0.00	-9.79
NOPAT Less CapEx to Interest Expense	-2.68	-7.78	-4.74	-4.00	-8.39	-13.71	-12.00	0.00	0.00	-6.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	24.58%	28.09%	23.86%	19.02%	15.86%	15.64%	9.51%	10.61%	9.19%	-2.75%	-4.61%
EBITDA Growth	63.76%	59.19%	34.49%	-4.92%	-30.94%	-41.83%	-63.61%	36.70%	-233.39%	-151.41%	-170.38%
EBIT Growth	50.78%	25.78%	25.07%	-2.60%	-21.52%	-14.49%	-37.52%	27.55%	-473.56%	-88.79%	-326.20%
NOPAT Growth	47.07%	25.78%	11.96%	-3.09%	-18.41%	-14.49%	-29.61%	20.91%	-350.16%	-88.79%	-241.67%
Net Income Growth	55.57%	8.70%	29.68%	-54.04%	-17.94%	-16.91%	-10.40%	27.94%	-743.97%	-43.84%	-542.63%
EPS Growth	60.98%	25.33%	38.10%	-47.06%	-13.89%	-13.64%	-8.62%	29.17%	-754.55%	-43.48%	-546.15%
Operating Cash Flow Growth	45.32%	104.75%	-17.36%	-125.08%	-10.10%	-157.86%	69.19%	33.14%	-414.75%	11.07%	-249.04%
Free Cash Flow Firm Growth	-16.44%	-7.73%	7.88%	60.74%	51.79%	40.84%	-8.62%	-17.62%	-536.97%	-137.34%	-216.64%
Invested Capital Growth	1.19%	0.01%	1.03%	-1.25%	-2.21%	-1.86%	0.94%	4.15%	2.72%	1.79%	1.54%
Revenue Q/Q Growth	1.10%	9.13%	1.02%	11.76%	3.95%	5.53%	-2.92%	8.80%	3.75%	-0.06%	-1.95%
EBITDA Q/Q Growth	6.72%	12.38%	39.82%	26.32%	-9.03%	-40.64%	3.63%	8.05%	-17.82%	-62.24%	62.71%
EBIT Q/Q Growth	31.16%	-28.73%	29.70%	21.00%	-3.81%	-29.96%	3.73%	6.43%	2.20%	-56.10%	49.28%
NOPAT Q/Q Growth	27.87%	-16.24%	17.73%	23.27%	-1.15%	-37.89%	3.66%	11.88%	2.20%	-56.10%	41.21%
Net Income Q/Q Growth	45.96%	-56.85%	57.64%	-23.77%	-11.04%	-20.81%	7.22%	5.24%	-10.06%	-14.08%	39.44%
EPS Q/Q Growth	42.86%	-43.59%	61.00%	-21.95%	-9.33%	-19.05%	7.35%	5.56%	-9.09%	-13.79%	39.58%
Operating Cash Flow Q/Q Growth	-3,753.06%	105.29%	47.81%	45.77%	-217.58%	-30.57%	-0.09%	73.47%	-643.81%	84.40%	-117.23%
Free Cash Flow Firm Q/Q Growth	1.11%	8.43%	-44.39%	10.94%	8.51%	21.70%	38.46%	-9.37%	-12.25%	-43.77%	33.36%
Invested Capital Q/Q Growth	3.89%	-3.23%	0.57%	0.07%	2.68%	-2.23%	-1.70%	-0.90%	3.05%	0.55%	1.42%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.20%	72.86%	76.64%	76.43%	76.34%	77.06%	76.28%	75.00%	75.55%	75.82%	76.34%
EBITDA Margin	-10.85%	-11.76%	-14.65%	-24.60%	-37.31%	-36.92%	-27.70%	-27.91%	-33.02%	-30.10%	-18.54%
Operating Margin	-19.39%	-27.17%	-25.51%	-31.32%	-45.63%	-46.89%	-35.89%	-36.16%	-44.65%	-47.36%	-30.32%
EBIT Margin	-18.50%	-27.17%	-23.04%	-33.10%	-46.83%	-46.89%	-38.08%	-38.40%	-44.65%	-47.36%	-30.32%
Profit (Net Income) Margin	-17.01%	-31.83%	-22.15%	-52.82%	-47.70%	-44.65%	-39.01%	-40.81%	-46.86%	-44.17%	-38.69%
Tax Burden Percent	101.83%	99.66%	100.83%	100.66%	100.93%	100.17%	100.12%	101.34%	101.17%	100.96%	100.90%
Interest Burden Percent	90.31%	117.54%	95.34%	158.53%	100.92%	95.07%	102.32%	104.88%	103.73%	92.38%	126.46%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-11.99%	-16.45%	-14.12%	-16.35%	-22.65%	-23.09%	-16.90%	-16.62%	-19.67%	-20.95%	-13.57%
ROIC Less NNEP Spread (ROIC-NNEP)	-9.53%	-8.56%	-10.59%	8.57%	47.07%	-2.97%	0.62%	0.31%	-7.38%	-13.87%	-3.92%
Return on Net Nonoperating Assets (RNNOA)	2.35%	2.38%	2.17%	-1.76%	-1.90%	0.29%	-0.08%	-0.04%	1.25%	2.75%	0.88%
Return on Equity (ROE)	-9.64%	-14.07%	-11.95%	-18.11%	-24.55%	-22.80%	-16.98%	-16.66%	-18.42%	-18.19%	-12.69%
Cash Return on Invested Capital (CROIC)	-17.08%	-19.33%	-21.35%	-19.46%	-18.26%	-18.26%	-20.14%	-22.24%	-21.75%	-14.64%	-11.96%
Operating Return on Assets (OROA)	-7.88%	-10.88%	-8.85%	-12.06%	-16.04%	-15.19%	-11.81%	-11.47%	-12.75%	-13.06%	-8.34%
Return on Assets (ROA)	-7.25%	-12.75%	-8.51%	-19.24%	-16.34%	-14.47%	-12.10%	-12.19%	-13.38%	-12.18%	-10.64%
Return on Common Equity (ROCE)	-9.64%	-14.07%	-11.95%	-18.11%	-24.55%	-22.80%	-16.98%	-16.66%	-18.42%	-18.19%	-12.69%
Return on Equity Simple (ROE_SIMPLE)	-16.19%	0.00%	-22.37%	-23.84%	-31.25%	0.00%	-27.08%	-25.87%	-27.37%	0.00%	-16.34%
Net Operating Profit after Tax (NOPAT)	-14	-20	-17	-21	-27	-27	-20	-20	-23	-24	-15
NOPAT Margin	-13.57%	-19.02%	-17.86%	-21.93%	-31.94%	-32.82%	-25.12%	-25.31%	-31.25%	-33.15%	-21.23%
Net Nonoperating Expense Percent (NNEP)	-2.46%	-7.90%	-3.53%	-24.92%	-69.72%	-20.11%	-17.52%	-16.93%	-12.30%	-7.07%	-9.65%
Return On Investment Capital (ROIC_SIMPLE)	-1.89%	-2.62%	-	-	-	-3.63%	-	-	-	-2.91%	-
Cost of Revenue to Revenue	22.80%	27.14%	23.36%	23.57%	23.66%	22.94%	23.72%	25.00%	24.45%	24.18%	23.66%
SG&A Expenses to Revenue	66.26%	65.41%	66.20%	69.17%	72.38%	76.53%	69.50%	66.09%	72.60%	72.90%	66.16%
R&D to Revenue	30.33%	34.62%	35.94%	38.59%	49.58%	47.43%	42.67%	45.07%	47.59%	50.28%	40.51%
Operating Expenses to Revenue	96.59%	100.03%	102.15%	107.76%	121.97%	123.96%	112.17%	111.16%	120.19%	123.18%	106.66%
Earnings before Interest and Taxes (EBIT)	-20	-29	-22	-32	-40	-39	-30	-31	-33	-34	-22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-12	-14	-24	-32	-30	-22	-22	-24	-21	-13
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.29	10.78	10.71	8.96	10.21	8.40	7.66	7.02	4.72	3.93	4.62
Price to Tangible Book Value (P/TBV)	12.65	18.90	21.50	18.44	44.81	34.43	29.92	26.97	17.04	13.36	15.05
Price to Revenue (P/Rev)	13.76	21.56	19.87	17.44	14.10	12.33	12.06	11.57	8.30	7.37	8.90
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	11.44	17.93	15.18	12.64	10.13	8.72	8.03	7.40	5.08	4.46	5.46
Enterprise Value to Revenue (EV/Rev)	13.02	20.73	19.30	16.84	14.13	12.29	12.00	11.49	8.17	7.11	8.61
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.08	0.09	0.63	0.61	0.59	0.58	0.55	0.53	0.51
Long-Term Debt to Equity	0.00	0.00	0.08	0.09	0.63	0.61	0.59	0.58	0.55	0.53	0.51
Financial Leverage	-0.25	-0.28	-0.20	-0.21	-0.04	-0.10	-0.12	-0.14	-0.17	-0.20	-0.22
Leverage Ratio	1.56	1.56	1.64	1.63	1.99	1.96	1.91	1.89	1.83	1.84	1.80
Compound Leverage Factor	1.41	1.83	1.56	2.58	2.01	1.86	1.95	1.98	1.90	1.70	2.28
Debt to Total Capital	0.00%	0.00%	7.83%	7.85%	38.58%	37.98%	37.16%	36.59%	35.65%	34.68%	33.88%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	7.83%	7.85%	38.58%	37.98%	37.16%	36.59%	35.65%	34.68%	33.88%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	92.17%	92.15%	61.42%	62.02%	62.84%	63.41%	64.35%	65.32%	66.12%
Debt to EBITDA	0.00	0.00	-0.60	-0.57	-2.90	-2.97	-3.30	-3.57	-3.20	-6.25	-8.76
Net Debt to EBITDA	0.00	0.00	2.16	2.08	-0.11	0.13	0.22	0.28	0.41	1.58	2.51
Long-Term Debt to EBITDA	0.00	0.00	-0.60	-0.57	-2.90	-2.97	-3.30	-3.57	-3.20	-6.25	-8.76
Debt to NOPAT	0.00	0.00	-0.61	-0.60	-3.00	-3.14	-3.26	-3.43	-3.22	-4.88	-6.04
Net Debt to NOPAT	0.00	0.00	2.22	2.16	-0.11	0.14	0.21	0.26	0.41	1.24	1.73
Long-Term Debt to NOPAT	0.00	0.00	-0.61	-0.60	-3.00	-3.14	-3.26	-3.43	-3.22	-4.88	-6.04
Altman Z-Score	16.23	23.56	16.30	13.67	5.38	4.58	4.47	4.25	3.00	2.61	3.38
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	6.49	5.99	5.54	5.48	5.38	5.34	5.95	6.28	6.67	6.13	7.40
Quick Ratio	5.40	5.05	4.45	4.46	4.42	4.53	5.07	5.37	5.70	5.37	6.54
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	-20	-22	-15	-17	-19	-24	-39	-35	-32	-22
Operating Cash Flow to CapEx	-955.68%	29.26%	-661.10%	-854.77%	-3,498.97%	-253.09%	-243.10%	-141.54%	-445.34%	-50.65%	-439.06%
Free Cash Flow to Firm to Interest Expense	-17.09	-2.56	-13.20	-0.71	-4.95	-4.68	-7.01	-11.39	-10.39	-3.86	-6.30
Operating Cash Flow to Interest Expense	-15.93	0.06	-5.76	-0.86	-9.82	-2.68	-2.40	-2.40	-9.03	-0.51	-7.62
Operating Cash Flow Less CapEx to Interest Expense	-17.59	-0.16	-6.64	-0.96	-10.10	-3.73	-3.39	-4.10	-11.05	-1.50	-9.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.43	0.40	0.38	0.36	0.34	0.32	0.31	0.30	0.29	0.28	0.27
Accounts Receivable Turnover	6.85	7.62	7.53	7.55	7.74	8.29	8.19	7.88	7.96	8.14	8.14
Inventory Turnover	1.79	1.89	1.69	1.67	1.72	1.89	2.00	2.15	2.15	2.27	2.55
Fixed Asset Turnover	4.07	3.81	3.57	3.37	3.26	3.19	3.19	3.23	3.34	3.46	3.85
Accounts Payable Turnover	6.86	7.11	7.83	7.97	6.28	5.43	6.76	4.84	6.99	6.35	6.89
Days Sales Outstanding (DSO)	53.27	47.87	48.49	48.32	47.18	44.03	44.54	46.29	45.87	44.85	44.85
Days Inventory Outstanding (DIO)	204.01	193.44	215.83	218.26	212.72	192.77	182.64	169.95	169.92	161.00	143.35
Days Payable Outstanding (DPO)	53.17	51.37	46.59	45.79	58.16	67.24	54.02	75.41	52.22	57.51	52.99
Cash Conversion Cycle (CCC)	204.11	189.95	217.73	220.79	201.75	169.56	173.16	140.83	163.57	148.34	135.21
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	461	443	458	455	455	443	453	461	465	452	449
Invested Capital Turnover	0.88	0.87	0.79	0.75	0.71	0.70	0.67	0.66	0.63	0.63	0.64
Increase / (Decrease) in Invested Capital	5.40	0.03	4.69	-5.78	-10	-8.38	4.22	18	12	7.92	6.81
Enterprise Value (EV)	5,269	7,948	6,953	5,756	4,612	3,866	3,642	3,411	2,363	2,012	2,453
Market Capitalization	5,567	8,267	7,159	5,961	4,601	3,879	3,661	3,433	2,399	2,084	2,534
Book Value per Share	$13.51	$13.91	$12.17	$13.21	$9.09	$9.46	$9.82	$10.14	$10.62	$11.11	$11.53
Tangible Book Value per Share	$7.78	$7.93	$6.06	$6.42	$2.07	$2.31	$2.51	$2.64	$2.94	$3.27	$3.54
Total Capital	764	767	725	722	734	745	760	771	790	811	830
Total Debt	0.00	0.00	57	57	283	283	282	282	282	281	281
Total Long-Term Debt	0.00	0.00	57	57	283	283	282	282	282	281	281
Net Debt	-299	-319	-206	-205	10	-13	-18	-22	-36	-71	-81
Capital Expenditures (CapEx)	1.94	1.73	1.45	2.15	0.97	4.21	3.36	5.77	6.91	8.17	6.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)	77	56	63	52	44	26	32	34	36	19	27
Debt-free Net Working Capital (DFNWC)	376	375	326	314	316	321	332	337	353	372	388
Net Working Capital (NWC)	376	375	326	314	316	321	332	337	353	372	388
Net Nonoperating Expense (NNE)	3.67	14	4.15	30	13	9.74	11	12	12	7.85	12
Net Nonoperating Obligations (NNO)	-303	-324	-210	-210	4.40	-19	-24	-28	-43	-78	-99
Total Depreciation and Amortization (D&A)	8.16	16	8.10	8.14	8.15	8.21	8.10	8.44	8.59	12	8.40
Debt-free, Cash-free Net Working Capital to Revenue	19.11%	14.54%	17.52%	15.23%	13.33%	8.27%	10.38%	11.31%	12.36%	6.65%	9.34%
Debt-free Net Working Capital to Revenue	92.95%	97.70%	90.36%	91.80%	96.92%	102.14%	109.49%	113.67%	122.28%	131.34%	136.28%
Net Working Capital to Revenue	92.95%	97.70%	90.36%	91.80%	96.92%	102.14%	109.49%	113.67%	122.28%	131.34%	136.28%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.32)	($0.56)	($0.39)	($1.00)	($0.82)	($0.75)	($0.63)	($0.68)	($0.72)	($0.66)	($0.58)
Adjusted Weighted Average Basic Shares Outstanding	56.64M	52.76M	55.04M	50.72M	49.58M	48.43M	48.68M	48.28M	47.88M	47.44M	47.61M
Adjusted Diluted Earnings per Share	($0.32)	($0.56)	($0.39)	($1.00)	($0.82)	($0.75)	($0.63)	($0.68)	($0.72)	($0.66)	($0.58)
Adjusted Weighted Average Diluted Shares Outstanding	56.64M	52.76M	55.04M	50.72M	49.58M	48.43M	48.68M	48.28M	47.88M	47.44M	47.61M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	57.14M	56.57M	55.14M	54.95M	50.37M	49.47M	48.80M	48.65M	48.21M	47.88M	47.70M
Normalized Net Operating Profit after Tax (NOPAT)	-14	-20	-17	-21	-27	-27	-20	-20	-23	-24	-15
Normalized NOPAT Margin	-13.57%	-19.02%	-17.86%	-21.93%	-31.94%	-32.82%	-25.12%	-25.31%	-31.25%	-33.15%	-21.23%
Pre Tax Income Margin	-16.71%	-31.94%	-21.96%	-52.48%	-47.26%	-44.58%	-38.96%	-40.27%	-46.31%	-43.75%	-38.35%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-16.97	-3.65	-13.39	-1.48	-11.62	-9.69	-8.75	-9.08	-9.68	-4.12	-6.21
NOPAT to Interest Expense	-12.45	-2.55	-10.38	-0.98	-7.93	-6.78	-5.77	-5.99	-6.78	-2.89	-4.35
EBIT Less CapEx to Interest Expense	-18.63	-3.87	-14.26	-1.58	-11.90	-10.75	-9.73	-10.78	-11.71	-5.12	-7.94
NOPAT Less CapEx to Interest Expense	-14.11	-2.77	-11.25	-1.08	-8.21	-7.84	-6.76	-7.68	-8.80	-3.89	-6.08
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Glaukos' Financials

When does Glaukos's fiscal year end?

According to the most recent income statement we have on file, Glaukos' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Glaukos' net income changed over the last 9 years?

Glaukos' net income appears to be on an upward trend, with a most recent value of -$146.37 million in 2024, rising from -$38.32 million in 2015. The previous period was -$134.66 million in 2023. Find out what analysts predict for Glaukos in the coming months.

What is Glaukos's operating income?

Glaukos's total operating income in 2024 was -$122.37 million, based on the following breakdown:

Total Gross Profit: $289.45 million
Total Operating Expenses: $411.82 million

How has Glaukos revenue changed over the last 9 years?

Over the last 9 years, Glaukos' total revenue changed from $71.70 million in 2015 to $383.48 million in 2024, a change of 434.8%.

How much debt does Glaukos have?

Glaukos' total liabilities were at $207.83 million at the end of 2024, a 56.6% decrease from 2023, and a 868.0% increase since 2015.

How much cash does Glaukos have?

In the past 9 years, Glaukos' cash and equivalents has ranged from $6.49 million in 2016 to $169.63 million in 2024, and is currently $169.63 million as of their latest financial filing in 2024.

How has Glaukos' book value per share changed over the last 9 years?

Over the last 9 years, Glaukos' book value per share changed from 2.97 in 2015 to 13.91 in 2024, a change of 369.1%.

Related Companies

This page (NYSE:GKOS) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Glaukos (GKOS) Financials

Frequently Asked Questions About Glaukos' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Glaukos (GKOS) Financials

Annual Income Statements for Glaukos

Quarterly Income Statements for Glaukos

Annual Cash Flow Statements for Glaukos

Quarterly Cash Flow Statements for Glaukos

Annual Balance Sheets for Glaukos

Quarterly Balance Sheets for Glaukos

Annual Metrics And Ratios for Glaukos

Quarterly Metrics And Ratios for Glaukos

Frequently Asked Questions About Glaukos' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools